EP3448399A4 - Verfahren und system zur charakterisierung von hautbezogenen bedingungen - Google Patents
Verfahren und system zur charakterisierung von hautbezogenen bedingungen Download PDFInfo
- Publication number
- EP3448399A4 EP3448399A4 EP17790288.9A EP17790288A EP3448399A4 EP 3448399 A4 EP3448399 A4 EP 3448399A4 EP 17790288 A EP17790288 A EP 17790288A EP 3448399 A4 EP3448399 A4 EP 3448399A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- related conditions
- characterizing skin
- characterizing
- skin
- conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Zoology (AREA)
- Theoretical Computer Science (AREA)
- Wood Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662327126P | 2016-04-25 | 2016-04-25 | |
| US201662327089P | 2016-04-25 | 2016-04-25 | |
| US201662327048P | 2016-04-25 | 2016-04-25 | |
| PCT/US2017/029470 WO2017189614A1 (en) | 2016-04-25 | 2017-04-25 | Method and system for characterizing skin related conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3448399A1 EP3448399A1 (de) | 2019-03-06 |
| EP3448399A4 true EP3448399A4 (de) | 2020-05-13 |
Family
ID=60160002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17790288.9A Pending EP3448399A4 (de) | 2016-04-25 | 2017-04-25 | Verfahren und system zur charakterisierung von hautbezogenen bedingungen |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3448399A4 (de) |
| CN (1) | CN109152803B (de) |
| AU (1) | AU2017257785A1 (de) |
| CA (1) | CA3022294A1 (de) |
| WO (1) | WO2017189614A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10973890B2 (en) | 2016-09-13 | 2021-04-13 | Allergan, Inc. | Non-protein clostridial toxin compositions |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014281553A1 (en) | 2013-06-18 | 2016-01-28 | Prodermiq, Inc. | Customized skin care products and personal care products based on the analysis of skin flora |
| WO2018165621A1 (en) | 2017-03-10 | 2018-09-13 | Prodermiq, Inc. | Customized skin care products and personal care products based on the analysis of skin flora |
| CN112352058A (zh) * | 2018-03-26 | 2021-02-09 | 普罗皮肤检测股份有限公司 | 用于治疗痤疮的组合物和方法 |
| BR112020017257A2 (pt) * | 2018-03-29 | 2020-12-22 | Kimberly-Clark Worldwide, Inc. | Sensor, artigo absorvente, e, método para indicar um potencial problema de pele ou gastrointestinal. |
| MX2024000046A (es) * | 2021-07-05 | 2024-02-21 | Unilever Ip Holdings B V | Metodo para evaluar una composicion cosmetica o componente de la misma. |
| WO2023280711A1 (en) * | 2021-07-05 | 2023-01-12 | Unilever Ip Holdings B.V. | Method for assessing skin |
| CN117337901B (zh) * | 2023-09-28 | 2026-04-24 | 广西农垦西江乳业有限公司 | 一种低致敏乳源蛋白基料的制备方法 |
| CN118272552B (zh) * | 2024-03-29 | 2025-02-14 | 美益添生物医药(武汉)有限公司 | 源于肠道菌群的白癜风检测标志物及其应用 |
| CN118230890A (zh) * | 2024-05-24 | 2024-06-21 | 西安润玉医疗科技有限公司 | 一种基于术后皮肤检测数据的产品匹配方法及系统 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013142378A1 (en) * | 2012-03-17 | 2013-09-26 | The Regents Of The University Of California | Fast diagnosis and personalized treatments for acne |
| WO2014205088A2 (en) * | 2013-06-18 | 2014-12-24 | Prodermiq | Customized skin care products and personal care products based on the analysis of skin flora |
| WO2015070086A1 (en) * | 2013-11-07 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free nucleic acids for the analysis of the human microbiome and components thereof |
| WO2015112352A2 (en) * | 2014-01-25 | 2015-07-30 | uBiome, Inc. | Method and system for microbiome analysis |
| WO2016065075A1 (en) * | 2014-10-21 | 2016-04-28 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| WO2016168350A1 (en) * | 2015-04-13 | 2016-10-20 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
| WO2017156031A1 (en) * | 2016-03-07 | 2017-09-14 | uBiome, Inc. | Method and system for characterizing mouth-associated conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120189621A1 (en) * | 2011-01-21 | 2012-07-26 | Yann Dean | Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists |
| WO2012158818A2 (en) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| US10131710B2 (en) * | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
| CA2896359A1 (en) * | 2013-02-26 | 2014-09-04 | Roche Glycart Ag | Bispecific t cell activating antigen binding molecules |
| CN105283201B (zh) * | 2013-03-14 | 2019-08-02 | 斯克利普斯研究所 | 靶向剂抗体偶联物及其用途 |
-
2017
- 2017-04-25 CA CA3022294A patent/CA3022294A1/en active Pending
- 2017-04-25 WO PCT/US2017/029470 patent/WO2017189614A1/en not_active Ceased
- 2017-04-25 AU AU2017257785A patent/AU2017257785A1/en not_active Abandoned
- 2017-04-25 EP EP17790288.9A patent/EP3448399A4/de active Pending
- 2017-04-25 CN CN201780030413.6A patent/CN109152803B/zh active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013142378A1 (en) * | 2012-03-17 | 2013-09-26 | The Regents Of The University Of California | Fast diagnosis and personalized treatments for acne |
| WO2014205088A2 (en) * | 2013-06-18 | 2014-12-24 | Prodermiq | Customized skin care products and personal care products based on the analysis of skin flora |
| WO2015070086A1 (en) * | 2013-11-07 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free nucleic acids for the analysis of the human microbiome and components thereof |
| WO2015112352A2 (en) * | 2014-01-25 | 2015-07-30 | uBiome, Inc. | Method and system for microbiome analysis |
| WO2016065075A1 (en) * | 2014-10-21 | 2016-04-28 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| WO2016168350A1 (en) * | 2015-04-13 | 2016-10-20 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
| WO2017156031A1 (en) * | 2016-03-07 | 2017-09-14 | uBiome, Inc. | Method and system for characterizing mouth-associated conditions |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10973890B2 (en) | 2016-09-13 | 2021-04-13 | Allergan, Inc. | Non-protein clostridial toxin compositions |
| US12144847B2 (en) | 2016-09-13 | 2024-11-19 | Allergan, Inc. | Non-protein clostridial toxin compositions |
| US12171816B2 (en) | 2016-09-13 | 2024-12-24 | Allergan, Inc. | Non-protein Clostridial toxin compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017257785A1 (en) | 2018-11-08 |
| CN109152803A (zh) | 2019-01-04 |
| CN109152803B (zh) | 2022-09-23 |
| WO2017189614A1 (en) | 2017-11-02 |
| EP3448399A1 (de) | 2019-03-06 |
| CA3022294A1 (en) | 2017-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3507742A4 (de) | System und verfahren zur charakterisierung von cannabaceae-pflanzen | |
| EP3635621A4 (de) | System und verfahren zur bildanonymisierung | |
| EP3811316C0 (de) | Blockchain system und verfahren | |
| EP3552137A4 (de) | System und verfahren zur erkennung von cryptoware | |
| EP3485435A4 (de) | System und verfahren zur automatischen lernen von funktionen | |
| EP3673345A4 (de) | System und verfahren zur verfolgung verteilter vorrichtungen | |
| EP3443685C0 (de) | System und verfahren zur strahlverwaltung | |
| EP3576707C0 (de) | System und verfahren zur benutzerabsichtserkennung | |
| EP3697736C0 (de) | System zur bereitstellung von markierten behältern und verfahren dafür | |
| EP3844553C0 (de) | Verfahren und system zur blickkalkulation | |
| EP3596960A4 (de) | Präzises positionierungssystem und verfahren zur verwendung desselben | |
| EP3448399A4 (de) | Verfahren und system zur charakterisierung von hautbezogenen bedingungen | |
| EP3349040C0 (de) | Verfahren zur positionierung von unterwasserobjekten und system zur durchführung davon | |
| EP3548440A4 (de) | Flüssigkeitsbehandlungssysteme und verfahren zur verwendung davon | |
| EP3503033C0 (de) | System zur optischen verfolgung und verfahren zur optischen verfolgung | |
| EP3308608C0 (de) | System und verfahren zur visuellen verfolgung | |
| EP3622476A4 (de) | System und verfahren zur bildverarbeitung | |
| EP3640333A4 (de) | System und verfahren zur geneditierung | |
| EP3422939A4 (de) | Verfahren und system zur bildgebung | |
| EP3600549A4 (de) | System und verfahren zur bereitstellung von strahlentherapie | |
| DE112018000912A5 (de) | Verfahren und Vorrichtung zur Beatmung | |
| EP3544648A4 (de) | Chirurgisches system und verfahren zur verwendung | |
| EP3652693C0 (de) | Verfahren und system zur netzwerkübergreifenden authentifizierung | |
| EP3079098C0 (de) | Verfahren und system zur geodemografischen klassifizierung einer geografischen region | |
| EP3512423A4 (de) | System und verfahren zur charakterisierung von atemstress |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20181024 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0035740000 Ipc: C12Q0001689000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20200417 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: G06F 17/00 20190101ALI20200408BHEP Ipc: C12Q 1/689 20180101AFI20200408BHEP |
|
| 19U | Interruption of proceedings before grant |
Effective date: 20191011 |
|
| 19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20201201 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PSOMAGEN, INC. |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20230905 |